Juan C. Osorio - Department of Medicine, Harvard Medical School

基本信息

Career Trajectory

Bio

Juan C. Osorio currently works as medical oncology fellow at Memorial Sloan Kettering Cancer Center. Juan does research in pulmonary diseases including pulmonary fibrosis and lung cancer. Their current project is 'Immune-related adverse effects with Check-point inhibitors.'

Research Interests

Papers共 83 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT086: Phase I Study of Intravesical Fc-optimized Anti-Cd40 Agonist Antibody 2141-V11 for Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy

Juan C. Osorio,Muneeb Alam, Jeffrey Wong,David Knorr,Lucas Blanchard, Juan C. Angulo-Lozano,Karissa Whiting,Venkatraman E. Seshan,Timothy F. Donahue,Eugene K. Cha,Alvin C. Goh,Robert Smith,Guido Dalbagni,Christian Hernandez,Melissa McCarter,Eugene J. Pietzak,Jonathan E. Rosenberg,Jeffrey V. Ravetch,Bernard H. Bochner

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Intratumoral Fc-optimized Agonistic CD40 Antibody Induces Tumor Rejection and Systemic Antitumor Immunity in Patients with Metastatic Cancer

Juan C Osorio,David A Knorr,Polina Weitzenfeld, Ning Yao,Maria Baez, Meghan DiLillo,Jahan Rahman,Jacqueline Bromberg,Michael A Postow,Charlotte Ariyan,Mark E Robson,Jeffrey V Ravetch

Research square (2024)

Cited0Views0WOSBibtex

Supplementary Figure 1 from FcγRIIB is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

David A. Knorr,Lucas Blanchard,Rom S. Leidner,Shawn M. Jensen,Ryan Meng,Andrew Jones,Carmen Ballesteros-Merino,Richard B. Bell,Maria Baez, Alessandra Marino,David Sprott,Carlo B. Bifulco,Brian Piening,Rony Dahan,Juan C. Osorio,Bernard A. Fox,Jeffrey V. Ravetch

crossref（2024）

Cited0Views0Bibtex

Endometrial Carcinoma in Black Vs Asian Women: Racial Disparities and Opportunities to Improve Survival in 219,301 Patients in the USA

Henry Alberto Becerra,Nosakhare Paul Ilerhunmwuwa,Mustafa Wasifuddin,Ifeanyi Uche,Juan C. Osorio, Jen Chin C. Wang

Journal of Clinical Oncologyno. 16_suppl (2024): 5608-5608

Cited0Views0Bibtex

Abstract PR-11: Fc-optimized Agonistic CD40 Antibody Induces Tumor Rejection and Systemic Antitumor Immunity - from the Bench to the Bedside and Back

Polina Weitzenfeld,Juan C Osorio,Jeffrey V Ravetch

Cancer Immunology Researchno. 10_Supplement (2024)

Cited0Views0Bibtex

Supplementary Table 2 from FcγRIIB is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

crossref（2024）

Cited0Views0Bibtex

615 Intratumoral Fc-engineered Agonistic CD40 Antibody Induces Tumor Rejection and Systemic Antitumor Immunity in Metastatic Cancer Patients. A Bench-to-bedside and Back Approach

Juan C Osorio,David A Knorr,Polina Weitzenfeld, Ning Yao,Maria Baez, Meghan DiLillo,Jahan Rahman,Jacqueline Bromberg,Michael Postow,Charlotte Ariyan, Mark Robson,Jeffrey V Ravetch

Regular and Young Investigator Award Abstracts (2024)

Cited0Views0Bibtex

Body Mass Index and Adiposity Influence Responses to Immune Checkpoint Inhibition in Endometrial Cancer

Nicolas Gomez-Banoy,Eduardo J. Ortiz,Caroline S. Jiang,Christian Dagher, Carlo Sevilla,Jeffrey Girshman,Andrew M. Pagano,Andrew J. Plodkowski,William A. Zammarrelli,Jennifer J. Mueller,Carol Aghajanian,Britta Weigelt,Vicky Makker,Paul Cohen,Juan C. Osorio

Journal of Clinical Investigation (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn